LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
![Foto de LUIS GONZAGA](/img/nophoto.png)
![Foto de Hospital Universitario Virgen de la Victoria](/img/noimage_org.png)
Hospital Universitario Virgen de la Victoria
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (16)
2024
-
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 2, pp. 192-204
-
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
Lung Cancer, Vol. 189
-
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastases
Lung Cancer, Vol. 188
-
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium
Clinical and Translational Oncology, Vol. 26, Núm. 2, pp. 352-362
2022
-
Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer
Expert Opinion on Emerging Drugs, Vol. 27, Núm. 3, pp. 289-300
2021
-
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Cancer Medicine, Vol. 10, Núm. 17, pp. 5878-5888
2020
-
Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus
Clinical and Translational Oncology, Vol. 22, Núm. 5, pp. 759-771
2017
-
A consensus statement on the gender perspective in lung cancer
Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 527-535
-
Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy
Clinical and Translational Oncology, Vol. 19, Núm. 2, pp. 219-226
2014
-
MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer
BMC Cancer, Vol. 14, Núm. 1
2013
2012
-
Recommendations for the optimal management of early and advanced urothelial carcinoma
Cancer Treatment Reviews, Vol. 38, Núm. 5, pp. 431-441
-
The role of pharmacogenomics in metastatic renal cell carcinoma
Cancer and Metastasis Reviews, Vol. 31, pp. S29-S32
2010
2009
-
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma
European Journal of Cancer, Vol. 45, Núm. 5, pp. 732-735
-
SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)
Clinical and Translational Oncology